Appraisal of Myeloperoxidase for Evaluation of Patients With Suspected Acute Coronary Syndromes
- 22 May 2007
- journal article
- editorial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 49 (20) , 2001-2002
- https://doi.org/10.1016/j.jacc.2007.03.010
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Plasma Concentrations of Myeloperoxidase Predict Mortality After Myocardial InfarctionJournal of the American College of Cardiology, 2007
- Heparins Increase Endothelial Nitric Oxide Bioavailability by Liberating Vessel-Immobilized MyeloperoxidaseCirculation, 2006
- Myeloperoxidase and Cardiovascular DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Hypochlorous Acid, a Macrophage Product, Induces Endothelial Apoptosis and Tissue Factor ExpressionArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Prognostic Value of Myeloperoxidase in Patients with Chest PainNew England Journal of Medicine, 2003
- Future of Biomarkers in Acute Coronary SyndromesCirculation, 2003
- Stabilization of atherosclerotic plaques: New mechanisms and clinical targetsNature Medicine, 2002
- Association Between Myeloperoxidase Levels and Risk of Coronary Artery DiseaseJAMA, 2001
- Nitric Oxide Is a Physiological Substrate for Mammalian PeroxidasesJournal of Biological Chemistry, 2000
- 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima.Journal of Clinical Investigation, 1997